Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Athanasios Apostolos Gargavanis"'
Autor:
Katharine Holt, Evi Charitou, Amy Lewis, Sara Halimah, Anna Karapatsia, Benjamin Polatidis, Athanasios Apostolos Gargavanis, Anne Ahlmann Nielsen, Georgios Ioannis Tsianos, Christian Bjerregaard Olesen, Efstathios Vassiliadis, Doros Polydorou, Marinela Cebic
Publikováno v:
Journal of Advanced Research in Medical Science & Technology. :4-10
On March 11th 2020, COVID-19 met all criteria to be considered a pandemic. The resulting halt in surgery led to an estimated 28.4 million elective surgery cancellations around the globe. Figures suggest that the backlog to surgery may take years to c
Autor:
Dimitrios Giakoustidis, Athanasios Apostolos Gargavanis, Kali Makedou, Thomas Goulopoulos, Alexander Giakoustidis, George Mosialos, Hara Afaloniati, Theofilos Poutahidis, Alexandros Hardas, Stavros Iliadis, Katerina Angelopoulou, Athanasios Pseftogas, Vasileios Papadopoulos, Apostolos Papalois
Publikováno v:
OncoTargets and Therapy. 13:5575-5588
Background Hepatocellular carcinoma (HCC) is a frequently diagnosed cancer and a leading cause of cancer-related death worldwide. Its rapid progression, combined with the limited treatment options at late stages, imposes the need for early detection
Autor:
Alexander Giakoustidis, Dimitrios Giakoustidis, Katerina Angelopoulou, Hara Afaloniati, Theofilos Poutahidis, Athanasios Apostolos Gargavanis
Publikováno v:
Molecular biology reports. 48(1)
Recently, our group showed that Romidepsin, a histone deacetylase inhibitor (HDACi), suppressed diethylnitrosamine (DEN)-induced hepatocellular carcinoma (HCC) in mice. In the present study, we investigated the effect of Romidepsin-treatment on gene
Autor:
Anne Ahlmann Nielsen, Efstathios Vassiliadis, Angeliki Koukoura, Georgios-Ioannis Tsianos, Amy Lewis, Athanasios Apostolos Gargavanis
Publikováno v:
Transplantation reviews (Orlando, Fla.). 35(2)
Organ donation and transplantation remain the best and most cost-effective clinical solution for end-stage organ failure. Several agencies across the US and Europe provide legislative, regulatory, and humanitarian services to generate smoother applic
Autor:
George Saridis, Apostolos Papalois, Nikolaos Psychalakis, Dimitrios Giakoustidis, Athanasios Apostolos Gargavanis, Paola Andreani, Alexander Hardas, Nikolaos Antoniadis, Argyro Zacharioudaki, Theofilos Poutahidis, Eleni Louri, Alexander Giakoustidis, Satvinder Mudan, Kali Makedou, Paschalis Gavriilidis, Daniel Azoulay, Stavros Iliadis, Eleftheria Karampela, Katerina Angelopoulou, Antonios Michalopoulos
Publikováno v:
Journal of Cancer
Background: To elucidate the expression of Aurora kinases (AURK) and the anticancer effects of pan-aurora kinase inhibitor Danusertib in hepatocarcinogenesis model in C56Bl6 mice. Methods: Thirty mice C56Bl6 were randomly divided into Group A or cont
Autor:
Efstratios Photiou, Dimitrios Liasis, Konstantinos Diamantopoulos, Dimitrios Giakoustidis, Elena Riza, Kyriaki A Kanistra, Athanasios Apostolos Gargavanis
Publikováno v:
Medicine, conflict, and survival. 35(2)
Autor:
Evangelos Cholongitas, Dimitrios Giakoustidis, Emmanouil Sinakos, Athanasios Apostolos Gargavanis, N. Salveridis, V. Papanikolaou, Konstantinos Papapolychroniadis
Publikováno v:
Hepatoma Research. 3
Autor:
Dimitrios Giakoustidis, Athanasios Apostolos Gargavanis, Evangelia D. Katsiki, Nikolaos Antoniadis, Vasileios Papanikolaou, N. Salveridis
Publikováno v:
Korean Journal of Hepato-Biliary-Pancreatic Surgery
Undifferentiated Embryonal Sarcoma of the Liver (UESL) is a tumor highly malignant, of mesenchymal origin. It is a rare finding in adults, though less rare in children. The strategy to be followed and the therapeutic targets to be reached for this tu
Autor:
Campeau K; English Department, University of Colorado Denver, 1051 Ninth Street Park, Denver, CO, 80204, USA. Kari.campeau@ucdenver.edu.
Publikováno v:
The Journal of medical humanities [J Med Humanit] 2023 Sep; Vol. 44 (3), pp. 369-394. Date of Electronic Publication: 2022 Oct 13.
This book covers advancements and future challenges in biomedical application development using disruptive technologies like artificial intelligence (AI), the Internet of Things (IoT), and signal processing. The book is divided into four main section